Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Molecules ; 26(13)2021 Jun 24.
Article in English | MEDLINE | ID: covidwho-1288959

ABSTRACT

The COVID-19 pandemic, as well as the more general global increase in viral diseases, has led researchers to look to the plant kingdom as a potential source for antiviral compounds. Since ancient times, herbal medicines have been extensively applied in the treatment and prevention of various infectious diseases in different traditional systems. The purpose of this review is to highlight the potential antiviral activity of plant compounds as effective and reliable agents against viral infections, especially by viruses from the coronavirus group. Various antiviral mechanisms shown by crude plant extracts and plant-derived bioactive compounds are discussed. The understanding of the action mechanisms of complex plant extract and isolated plant-derived compounds will help pave the way towards the combat of this life-threatening disease. Further, molecular docking studies, in silico analyses of extracted compounds, and future prospects are included. The in vitro production of antiviral chemical compounds from plants using molecular pharming is also considered. Notably, hairy root cultures represent a promising and sustainable way to obtain a range of biologically active compounds that may be applied in the development of novel antiviral agents.


Subject(s)
Antiviral Agents/pharmacology , COVID-19 Drug Treatment , Plant Extracts/pharmacology , Plants, Medicinal/chemistry , SARS-CoV-2/drug effects , Antiviral Agents/chemistry , Antiviral Agents/immunology , Antiviral Agents/therapeutic use , Computer Simulation , Humans , Molecular Farming/methods , Plant Extracts/chemistry , Plant Extracts/immunology , Plant Extracts/therapeutic use , Plants, Medicinal/immunology , SARS-CoV-2/physiology , Virus Replication/drug effects
2.
Int J Biol Macromol ; 181: 462-470, 2021 Jun 30.
Article in English | MEDLINE | ID: covidwho-1157350

ABSTRACT

The emergence of the novel coronavirus, SARS-CoV-2 has pushed forward the world to experience the first pandemic of this century. Any specific drug against this RNA virus is yet to be discovered and presently, the COVID-19 infected patients are being treated symptomatically. During the last few decades, a number of polysaccharides with potential biological activities have been invented from Indian medicinal plants. Many polysaccharides, such as sulfated xylomannan, xylan, pectins, fucoidans, glucans, glucoarabinan, and arabinoxylan from Indian medicinal plants, have been shown to exhibit antiviral and immunomodulating activities. Plant polysaccharides exhibit antiviral activities through interference with the viral life cycle and inhibition of attachment of virus to host cell. Intake of certain immune stimulating plant polysaccharides may also protect from the virus to a certain extent. In process of continuous search for most potent drug, Indian plant polysaccharides may emerge as significant biomaterial to combat COVID-19. This review explores a number of polysaccharides from Indian medicinal plants which showed antiviral and immunomodulating activities. It is aimed to provide an overview about the composition, molecular mass, branching configuration and related bioactivities of polysaccharides which is crucial for their classification as possible drug to induce immune response in viral diseases.


Subject(s)
COVID-19 Drug Treatment , Polysaccharides/pharmacology , Antiviral Agents/pharmacology , COVID-19/epidemiology , COVID-19/immunology , Humans , Immunity/drug effects , India/epidemiology , Pandemics , Plant Extracts/immunology , Plant Extracts/pharmacology , Plants, Medicinal/metabolism , Polysaccharides/immunology , SARS-CoV-2/drug effects , SARS-CoV-2/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL